World-Class Care with Heart

Endocrinology Research

This listing changes frequently.  For more information about the trials we have available, please contact us at (551) 996-5627 or via e-mail

20041318 / IV
Javier Aisenberg, MD
TrialNet Natural History Study of the Development of Type 1 Diabetes
Javier Aisenberg, MD
The Norditropin® National Registry
Javier Aisenberg, MD
GeNeSIS - The Genetics and Neuroendocrinology of Short Stature International Stu
20122135 / III
Steven Ghanny, MD
Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycemic control in children and adolescents with type 2 diabetes A 26-week double-blind, randomized, parallel group, placebo controlled multi-center trial followed by a 26-week open-label extension (NN2211-3659)
Steven Ghanny, MD
Integration of Technology in Diabetes Care (ITDC)
D20111828 / III
Jennifer Sivitz, M
A Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination with Metformin IR or Metformin XR in Pediatric Patients with Type 2 Diabetes who have inadequate Glycemic Control on Metformin Alone – CV181147

best-hospitals-cardiology    high-performing-indicator-heartfailure    high-performing-indicator-heartbypass     HG_Americas_50_Best_Award_Image_2014      HG_Americas_100_Best_Stroke_Care_Award_Image_2014        HG_Americas_100_Best_Pulmonary_Care_Award_Image_2014     red-bulllgbt      tkc_homepagelogo-2

Translation service provided by Google. Hackensack University Medical Center is not responsible for the accuracy of translation or any other
aspect of service provided by the GoogleTranslate tool. Users should not make medical decisions without first consulting
with their physician.
Site Map|Privacy Policy|Media Center
©2017 Hackensack University Medical Center. All rights reserved.
close (X)